• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of Commercial Investigational New Drugs Applications (INDs)/Investigational Drug Exemptions (IDEs) received in the month (1)

Dictionary: This measure shows the number of commercial, research, and emergency INDs / IDEs received in the month. An IND / IDE application is submitted to the FDA to request permission to conduct U.S. clinical trials using investigational products. Commercial INDs / IDEs reflect new products under development. Research INDs / IDEs reflect work that supports research and public health initiatives. Emergency INDs are requests to FDA, generally made by telephone, for an investigational drug to be used for the treatment of an individual patient by a licensed physician.

Information is current as of September 30, 2012

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/A5
Nov 2011N/A8
Dec 2011N/A15
Jan 2012N/A12
Feb 2012N/A10
Mar 2012N/A10
Apr 2012N/A7
May 2012N/A7
Jun 2012N/A6
Jul 2012N/A10
Aug 2012N/A5
Sep 2012N/A7

FY 2012 Total: 104

Footnotes

  • (1) Tracking against these measures did not start until July 2010

Number of Research IND/IDEs received in the month (1)

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/A20
Nov 2011N/A16
Dec 2011N/A13
Jan 2012N/A13
Feb 2012N/A13
Mar 2012N/A10
Apr 2012N/A17
May 2012N/A14
Jun 2012N/A18
Jul 2012N/A17
Aug 2012N/A17
Sep 2012N/A9

FY 2012 Total: 187

Number of Emergency IND/IDEs received in the month (1)

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber
Oct 2011N/A2
Nov 2011N/A2
Dec 2011N/A1
Jan 2012N/A1
Feb 2012N/A1
Mar 2012N/A4
Apr 2012N/A3
May 2012N/A3
Jun 2012N/A5
Jul 2012N/A3
Aug 2012N/A3
Sep 2012N/A5

FY 2012 Total: 35

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.